Characterization of Peripheral Circadian Clocks in Adipose Tissues
- Sanjin Zvonic1,
- Andrey A. Ptitsyn2,
- Steven A. Conrad3,
- L. Keith Scott3,
- Z. Elizabeth Floyd1,
- Gail Kilroy1,
- Xiying Wu1,
- Brian C. Goh1,
- Randall L. Mynatt1 and
- Jeffrey M. Gimble1
- 1Stem Cell Laboratory, Louisiana State University Pennington Biomedical Research Center, Baton Rouge, Louisiana
- 2Experimental Obesity Laboratory, Louisiana State University Pennington Biomedical Research Center, Baton Rouge, Louisiana
- 3Departments of Bioinformatics and Computational Biology, Medicine, and Emergency Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana
- Address correspondence and reprint requests to Jeffrey M. Gimble, 6400 Perkins Rd., Baton Rouge, LA 70808. E-mail: GimbleJM{at}pbrc.edu
Abstract
First described in the suprachiasmatic nucleus, circadian clocks have since been found in several peripheral tissues. Although obesity has been associated with dysregulated circadian expression profiles of leptin, adiponectin, and other fat-derived cytokines, there have been no comprehensive analyses of the circadian clock machinery in adipose depots. In this study, we show robust and coordinated expression of circadian oscillator genes (Npas2, Bmal1, Per1-3, and Cry1-2) and clock-controlled downstream genes (Rev-erbα, Rev-erbβ, Dbp, E4bp4, Stra13, and Id2) in murine brown, inguinal, and epididymal (BAT, iWAT, and eWAT) adipose tissues. These results correlated with respective gene expression in liver and the serum markers of circadian function. Through Affymetrix microarray analysis, we identified 650 genes that shared circadian expression profiles in BAT, iWAT, and liver. Furthermore, we have demonstrated that temporally restricted feeding causes a coordinated phase-shift in circadian expression of the major oscillator genes and their downstream targets in adipose tissues. The presence of circadian oscillator genes in fat has significant metabolic implications, and their characterization may have potential therapeutic relevance with respect to the pathogenesis and treatment of diseases such as obesity, type 2 diabetes, and the metabolic syndrome.
- BAT, brown adipose tissue
- bHLH-PAS, basic helix-loop-helix/Per-Arnt-Simpleminded
- DBP, albumin d-element–binding protein
- eWAT, epididymal adipose tissue
- iWAT, inguinal adipose tissue
- PAI-1, plasminogen activator inhibitor-1
- SCN, suprachiasmatic nucleus
Footnotes
-
X.W. holds stock in Eli Lilly and Pfizer. J.M.G. has served on advisory panels for Cognate Therapeutics, Artecel Sciences, Vesta Therapeutics, Vet-Stem, and Zen-Bio; holds stock in Eli Lilly and Pfizer; has received honoraria from Pfizer; and has been a paid consultant for Cognate Therapeutics, Artecel Sciences, and Anterogen.
-
Additional information for this article can be found in an online appendix at http://diabetes.diabetesjournals.org.
-
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Accepted December 20, 2005.
- Received July 8, 2005.
- DIABETES














